Position in GSK
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$927,834
-$49,029 QoQ
Shares Held
17,700
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#361
of 1,033 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quintet Private Bank (Europe) S.A. holds $89,967,099 across 12 Drug Manufacturers - General names. GSK ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
280,988 | $36,106,958 | |
| 2 | LLY |
ELI LILLY & Co
|
28,266 | $33,903,091 | |
| 3 | PFE |
Pfizer Inc
|
486,935 | $11,725,394 | |
| 4 | JNJ |
Johnson & Johnson
|
14,745 | $3,744,787 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
37,760 | $2,175,731 | |
| 6 | GSK |
GSK plc
This page
|
17,700 | $927,834 | |
| 7 | NVO |
Novo Nordisk A S
|
12,165 | $583,190 | |
| 8 | ABBV |
AbbVie Inc.
|
1,600 | $402,624 |
All Filings in GSK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $927,834 | 17,700 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $976,863 | 17,700 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $868,008 | 17,700 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $763,932 | 17,700 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $679,680 | 17,700 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $685,698 | 17,700 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $598,614 | 17,700 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $723,576 | 17,700 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $594,440 | 15,440 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $981,208 | 22,888 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||